| Ali A Mohammad, MD | |
|
3300 Nw Expressway, Oklahoma City, OK 73112-4418 | |
| (405) 713-7403 | |
| (405) 713-2794 |
| Full Name | Ali A Mohammad |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 52 Years |
| Location | 3300 Nw Expressway, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447215355 | NPI | - | NPPES |
| 100009600B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 10993 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Hospital Medicine Physicians Llc | 9830510023 | 110 |
News Archive
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
Researchers from the University of Leicester are working with the Youth Sport Trust to determine whether a school-based physical activity programme could help provide the key to encouraging adolescent girls to be active and stay active.
People with strong signs of autism spectrum disorder (ASD) show neural signs of anxiety when they see social touch and report unpleasant feelings about social touch by comparison to people with weak signs of ASD.
A study by PRICELESS-SA and partners shows that SA's 2018 "sugar tax" led to a reduction in purchases of sugar sweetened beverages (SSBs).
A report launched today by experts from medical and patient communities calls on Europe's policy makers to take urgent action against preventable strokes that strike thousands of atrial fibrillation (AF) patients each year
› Verified 8 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
Researchers from the University of Leicester are working with the Youth Sport Trust to determine whether a school-based physical activity programme could help provide the key to encouraging adolescent girls to be active and stay active.
People with strong signs of autism spectrum disorder (ASD) show neural signs of anxiety when they see social touch and report unpleasant feelings about social touch by comparison to people with weak signs of ASD.
A study by PRICELESS-SA and partners shows that SA's 2018 "sugar tax" led to a reduction in purchases of sugar sweetened beverages (SSBs).
A report launched today by experts from medical and patient communities calls on Europe's policy makers to take urgent action against preventable strokes that strike thousands of atrial fibrillation (AF) patients each year
› Verified 8 days ago
| Entity Name | Oklahoma Hospital Medicine Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871113761 PECOS PAC ID: 9830510023 Enrollment ID: O20200526000785 |
News Archive
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
Researchers from the University of Leicester are working with the Youth Sport Trust to determine whether a school-based physical activity programme could help provide the key to encouraging adolescent girls to be active and stay active.
People with strong signs of autism spectrum disorder (ASD) show neural signs of anxiety when they see social touch and report unpleasant feelings about social touch by comparison to people with weak signs of ASD.
A study by PRICELESS-SA and partners shows that SA's 2018 "sugar tax" led to a reduction in purchases of sugar sweetened beverages (SSBs).
A report launched today by experts from medical and patient communities calls on Europe's policy makers to take urgent action against preventable strokes that strike thousands of atrial fibrillation (AF) patients each year
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ali A Mohammad, MD 5300 N Independence Ave, Suite 280, Oklahoma City, OK 73112-5556 Ph: (405) 713-7403 | Ali A Mohammad, MD 3300 Nw Expressway, Oklahoma City, OK 73112-4418 Ph: (405) 713-7403 |
News Archive
MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.
Researchers from the University of Leicester are working with the Youth Sport Trust to determine whether a school-based physical activity programme could help provide the key to encouraging adolescent girls to be active and stay active.
People with strong signs of autism spectrum disorder (ASD) show neural signs of anxiety when they see social touch and report unpleasant feelings about social touch by comparison to people with weak signs of ASD.
A study by PRICELESS-SA and partners shows that SA's 2018 "sugar tax" led to a reduction in purchases of sugar sweetened beverages (SSBs).
A report launched today by experts from medical and patient communities calls on Europe's policy makers to take urgent action against preventable strokes that strike thousands of atrial fibrillation (AF) patients each year
› Verified 8 days ago
Evelyn Lorents, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |